Cidara Therapeutics (NASDAQ: CDTX)
$96.34
(0.6%)
$0.58
Price as of October 1, 2025, 4:00 p.m. ET
Cidara Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cidara Therapeutics Company Info
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
News & Analysis
Featured Article
Why Cidara Therapeutics Was Such a Healthy Stock Today
The company could have quite a winner on its hands with its most advanced pipeline drug.
Eric Volkman | Sep 26, 2025
Featured Article
Cidara (CDTX) Q2 Cash Surges 163%
Motley Fool Markets Team | Aug 7, 2025
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.